BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36122769)

  • 1. LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling.
    Gao F; Chen J; Zhang T; Liu N
    Exp Cell Res; 2022 Dec; 421(1):113360. PubMed ID: 36122769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
    Zeng YT; Liu XF; Yang WT; Zheng PS
    Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Shen L; Gu P; Qiu C; Ding WT; Zhang L; Cao WY; Li ZY; Yan B; Sun X
    Ann Hepatol; 2022; 27(3):100680. PubMed ID: 35108614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
    He T; Cui J; Wu Y; Sun X; Chen N
    Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
    Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
    Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of SOCS2 Inhibits EMT and M2 Macrophage Polarization in Cervical Cancer
    Li D; Huang Y; Wei M; Chen B; Lu Y
    Comb Chem High Throughput Screen; 2024; 27(7):984-995. PubMed ID: 37594110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma.
    Yang M; Yao P; Lang X; Li X; Zhang D
    Bioengineered; 2021 Dec; 12(2):12800-12811. PubMed ID: 34895038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the
    Liang YC; Li R; Bao SR; Li ZL; Yin HZ; Dai CL
    Hum Gene Ther; 2023 Aug; 34(15-16):719-731. PubMed ID: 37427415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
    Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
    Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.
    Wu Y; Yuan T; Wang WW; Ge PL; Gao ZQ; Zhang G; Tang Z; Dang XW; Zhao YF; Zhang JY; Jiang GZ
    Cell Physiol Biochem; 2018; 51(1):301-314. PubMed ID: 30453302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
    Miao JW; Liu LJ; Huang J
    Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
    Tao M; Luo J; Gu T; Yu X; Song Z; Jun Y; Gu H; Han K; Huang X; Yu W; Sun S; Zhang Z; Liu L; Chen X; Zhang L; Luo C; Wang Q
    Cell Death Dis; 2021 Sep; 12(9):845. PubMed ID: 34518524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2/STAT3 signaling mediated epithelial-mesenchymal transition.
    Zhou J; Hou J; Wang J; Wang J; Gao J; Bai Y
    Life Sci; 2021 Nov; 284():119907. PubMed ID: 34453950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway.
    Chen Y; Shao Z; Jiang E; Zhou X; Wang L; Wang H; Luo X; Chen Q; Liu K; Shang Z
    J Cell Physiol; 2020 Sep; 235(9):5995-6009. PubMed ID: 32017846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
    Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
    Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA AK089579 inhibits epithelial-to-mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA-296-3p via DOK2 in peritoneal fibrosis.
    Zhang XW; Wang L; Ding H
    FASEB J; 2019 Apr; 33(4):5112-5125. PubMed ID: 30652956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.